These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 21841204)
1. The first European Guidelines focussed on: management of dyslipidaemias. Taylor J Eur Heart J; 2011 Aug; 32(16):1949-50. PubMed ID: 21841204 [No Abstract] [Full Text] [Related]
2. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D; Atherosclerosis; 2011 Jul; 217 Suppl 1():S1-44. PubMed ID: 21723445 [No Abstract] [Full Text] [Related]
3. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus? Reiner Z Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):724-7. PubMed ID: 21945917 [No Abstract] [Full Text] [Related]
4. [A perspective to lipid lowering therapy after ESC/EAS guidelines for the management of dyslipidaemias and the European guidelines on cardiovascular disease prevention in clinical practice]. Ural D Turk Kardiyol Dern Ars; 2012 Jun; 40(4):293-7. PubMed ID: 22951844 [No Abstract] [Full Text] [Related]
5. [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: What is new?]. Kayıkçıoğlu M; Tokgözoğlu L Turk Kardiyol Dern Ars; 2017 Mar; 45(2):109-112. PubMed ID: 28424431 [No Abstract] [Full Text] [Related]
6. Treating dyslipidemia: re-evaluating the data using evidence-based medicine. Spratt KA J Am Osteopath Assoc; 2010 Apr; 110(4 Suppl 5):eS6-11. PubMed ID: 20430921 [No Abstract] [Full Text] [Related]
7. The new joint EAS/ESC guidelines for the management of dyslipidaemias. Catapano AL; Chapman J; Wiklund O; Taskinen MR Atherosclerosis; 2011 Jul; 217(1):1. PubMed ID: 21722901 [No Abstract] [Full Text] [Related]
8. [Dyslipidemias: is it necessary to treat or not treat? An approach based on scientific evidence in 2011]. Rodondi N Rev Med Suisse; 2011 May; 7(294):1037-8. PubMed ID: 21692326 [No Abstract] [Full Text] [Related]
9. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen MR; Wiklund O; Agewall S; Alegria E; Chapman M; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ; Atherosclerosis; 2011 Jul; 217(1):3-46. PubMed ID: 21882396 [No Abstract] [Full Text] [Related]
10. [How to apply clinical guidelines in medical practice? The example of dyslipidemia]. Pasche O; Pache S; Cornuz J; Darioli R; Rodondi N Rev Med Suisse; 2008 Mar; 4(148):662-5. PubMed ID: 18459662 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and management of the dyslipidemia of the metabolic syndrome. Raal FJ Metab Syndr Relat Disord; 2009 Apr; 7(2):83-8. PubMed ID: 19400742 [TBL] [Abstract][Full Text] [Related]
12. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). ; Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen MR; Tokgozoglu L; Verschuren WM; Vlachopoulos C; Wood DA; Zamorano JL Atherosclerosis; 2016 Oct; 253():281-344. PubMed ID: 27594540 [No Abstract] [Full Text] [Related]
13. The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk. Sulkes D; Brown BG; Krauss RM; Segrest JP; Sniderman AD; Roberts WC Am J Cardiol; 2008 Mar; 101(6):828-42. PubMed ID: 18328849 [No Abstract] [Full Text] [Related]
14. [Novel algorithms in treatment of dyslipidemia: comparative analysis of new American and European recommendations]. Mamedov MN; Kovrigina MN; Toguzova ZA Kardiologiia; 2015; 55(1):77-81. PubMed ID: 26050497 [TBL] [Abstract][Full Text] [Related]
15. [Update Dyslipidaemias - Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias]. Sinning D; Landmesser U Dtsch Med Wochenschr; 2017 Jun; 142(11):816-820. PubMed ID: 28564733 [No Abstract] [Full Text] [Related]
16. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement. Hegele RA; Borén J; Ginsberg HN; Arca M; Averna M; Binder CJ; Calabresi L; Chapman MJ; Cuchel M; von Eckardstein A; Frikke-Schmidt R; Gaudet D; Hovingh GK; Kronenberg F; Lütjohann D; Parhofer KG; Raal FJ; Ray KK; Remaley AT; Stock JK; Stroes ES; Tokgözoğlu L; Catapano AL Lancet Diabetes Endocrinol; 2020 Jan; 8(1):50-67. PubMed ID: 31582260 [TBL] [Abstract][Full Text] [Related]